Spectral Molecular Imaging (CSDT.OB) CEO Featured As Guest on MoneyTV This Week
Dr. Daniel L. Farkas, CEO of Spectral Molecular Imaging, a wholly-owned subsidiary of Cascade Technologies, appeared this week on MoneyTV, describing the company’s proprietary technology, and outlining Spectral’s plan for developing a line of optical imaging devices for the early detection of cancer, particularly melanoma. The application of the company’s proprietary spectral-optical imaging technology, originally developed for satellite reconnaissance, is expected to advance the diagnosis of cancer and precancerous conditions. Spectral is focused on non-invasive imaging systems for diagnostics, especially in the field of cancer pathology. Using high-resolution imaging, the devices can analyze certain tissue, cellular, and even molecular features,…